Krystal Biotech Operating Expenses Growth & History (KRYS)
Krystal Biotech's operating expenses was $227.8M for fiscal 2025.
View full Krystal Biotech company overviewKrystal Biotech annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $227.8M | $3.1M | +1.36% |
| 2024 | 2024-12-31 | $224.8M | $64.5M | +40.20% |
| 2023 | 2023-12-31 | $160.3M | $15.1M | +10.41% |
| 2022 | 2022-12-31 | $145.2M | $76.9M | +112.66% |
| 2021 | 2021-12-31 | $68.3M | $35.3M | +106.90% |
| 2020 | 2020-12-31 | $33.0M | $10.9M | +49.45% |
| 2019 | 2019-12-31 | $22.1M | $10.2M | +85.31% |
| 2018 | 2018-12-31 | $11.9M | $7.1M | +149.71% |
| 2017 | 2017-12-31 | $4.8M | $3.6M | +317.50% |
| 2016 | 2016-12-31 | $1.1M | — | — |
Krystal Biotech quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $60.8M | $4.2M | +7.35% |
| Q1 2026 | 2026-03-31 | $62.7M | $10.7M | +20.68% |
| Q4 2025 | 2025-12-31 | $62.8M | $13.1M | +26.31% |
| Q3 2025 | 2025-09-30 | $56.4M | −$4.9M | −8.05% |
| Q2 2025 | 2025-06-30 | $56.6M | −$5.1M | −8.22% |
| Q1 2025 | 2025-03-31 | $51.9M | −$3,000 | −0.01% |
| Q4 2024 | 2024-12-31 | $49.7M | $10.8M | +27.89% |
| Q3 2024 | 2024-09-30 | $61.4M | $26.8M | +77.63% |
| Q2 2024 | 2024-06-30 | $61.7M | $23.7M | +62.21% |
| Q1 2024 | 2024-03-31 | $51.9M | $3.1M | +6.37% |
| Q4 2023 | 2023-12-31 | $38.9M | $4.1M | +11.87% |
| Q3 2023 | 2023-09-30 | $34.5M | $3.1M | +9.85% |
| Q2 2023 | 2023-06-30 | $38.0M | $9.3M | +32.33% |
| Q1 2023 | 2023-03-31 | $48.8M | −$1.4M | −2.79% |
| Q4 2022 | 2022-12-31 | $34.8M | $12.9M | +58.93% |
| Q3 2022 | 2022-09-30 | $31.5M | $15.8M | +100.94% |
| Q2 2022 | 2022-06-30 | $28.8M | $12.4M | +75.40% |
| Q1 2022 | 2022-03-31 | $50.2M | $35.9M | +249.91% |
| Q4 2021 | 2021-12-31 | $21.9M | $11.5M | +109.97% |
| Q3 2021 | 2021-09-30 | $15.7M | $6.0M | +61.69% |
| Q2 2021 | 2021-06-30 | $16.4M | $9.4M | +135.73% |
| Q1 2021 | 2021-03-31 | $14.4M | $8.4M | +141.39% |
| Q4 2020 | 2020-12-31 | $10.4M | $4.3M | +69.28% |
| Q3 2020 | 2020-09-30 | $9.7M | $4.3M | +81.21% |
| Q2 2020 | 2020-06-30 | $7.0M | $1.1M | +18.06% |
| Q1 2020 | 2020-03-31 | $5.9M | $1.3M | +26.67% |
| Q4 2019 | 2019-12-31 | $6.2M | $1.9M | +45.92% |
| Q3 2019 | 2019-09-30 | $5.3M | $2.4M | +79.74% |
| Q2 2019 | 2019-06-30 | $5.9M | $3.4M | +140.51% |
| Q1 2019 | 2019-03-31 | $4.7M | $2.4M | +106.15% |
| Q4 2018 | 2018-12-31 | $4.2M | $2.7M | +181.39% |
| Q3 2018 | 2018-09-30 | $3.0M | $879,000 | +42.00% |
| Q2 2018 | 2018-06-30 | $2.4M | $1.7M | +242.52% |
| Q1 2018 | 2018-03-31 | $2.3M | $1.8M | +389.68% |
| Q4 2017 | 2017-12-31 | $1.5M | — | — |
| Q3 2017 | 2017-09-30 | $2.1M | $1.8M | +550.00% |
| Q2 2017 | 2017-06-30 | $715,000 | — | — |
| Q1 2017 | 2017-03-31 | $465,000 | — | — |
| Q3 2016 | 2016-09-30 | $322,000 | — | — |
Krystal Biotech operating expenses trends
Over the last five fiscal years, Krystal Biotech's operating expenses increased from $33.0M to $227.8M, a change of $194.8M. The latest reported quarter, Q2 2026, shows $60.8M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Krystal Biotech source filings ↗